Platform technologies

AI-guided INTENDD®

AI x INTENDD® – prediction of activity and beyond –

Small molecules (PPI modulators) designed by AI-guided INTENDD® will not require further activity optimization

In 2016, we have initiated the development of AI-based drug discovery program that integrates INTENDD® and deep learning in collaboration with AI Squared, Inc. We are working towards changing the existing paradigm of drug discovery by achieving accurate activity prediction using the highest-precision AI. Our ultimate goal is to realize the development of small molecule drugs with our AI technology that does not require chemical libraries.

Presentation Materials: Recent Progress of Interprotein’s Research Activities